The global compound management market is projected to reach USD 424.5 million in 2023 from USD 215.3 million in 2018, at CAGR of 14.5%. Increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management are the factors supporting the growth of this market. On the other hand, the large capital investments needed to establish compound management facilities is the major factor limiting market growth.
In this report, the market has been classified based on product & service, sample type, and end user. Based on product and service, the compound management market is segmented into product (instruments and software) & outsourcing services. In 2018, the products segment is expected to account for the largest share of the market. The outsourcing service segment is projected to grow at the highest rate during the forecast period. This high growth is attributed to the shift in trend towards outsourcing compound management to third-party service providers.
On the basis of sample type, the global compound management market is divided into chemical compounds and biosamples. In 2018, the chemical compounds segment is expected to account for the largest share of the global compound management market. The large share can be attributed to the high cost of large automated storage systems.
On the basis of end user, the global compound management products market is divided into pharmaceutical companies, biopharmaceutical companies, contract research organizations (CROs), biobanks, and other end users. In 2018, the pharmaceutical companies segment is expected to account for the largest share of the global compound management products market. The rising drug discovery activity is leading to an increased demand for compounds which is positively affecting the market growth.
One of the major factors restraining market growth is the high capital investments required to build a compound/sample management facility, including investment in both hardware and software, such as the installation of new automated liquid compound storage systems linked to a powerful inventory database. Due to this requirements, setting up such facilities may put them out of reach for small or medium-size pharmaceutical companies. Research institutes with limited budgets also find it difficult to afford such instruments. However, growth in the services market may alleviate problems of high capital investment.
Get Free Sample: https://www.marketsandmarkets.com/requestsample.asp?id=182172928
Key players that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (US), Labcyte (US), Biosero (US), and Tecan (Switzerland). Companies that provide compound management services include Evotec (Germany), Wuxi AppTec (China), Icagen (US), TCG Lifescience (India), and Frontier Scientific (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the compound management market.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com
